Abstract:Objectives: Cholangiocarcinoma (CCA) is the second-most common primary hepatic malignancy with an increasing incidence over the past two decades. CCA arises from the epithelial cells lining the bile ducts and can be classified as intrahepatic, perihilar, or distal based on the site of origin in the biliary tree. Surgical resection is the definitive curative therapy for early-stage intrahepatic CCA; however, only a minority of patients may be ideal surgical candidates. Percutaneous microwave ablation (MWA) is a minimally invasive procedure widely used for hepatocellular carcinoma and colorectal cancer metastases to the liver. Growing evidence suggests MWA can play a role in the management of patients with early-stage intrahepatic CCA. In this study, we aim to describe the safety and efficacy of MWA for the management of intrahepatic CCA. Material and methods: A retrospective review of patients with intrahepatic CCA treated with MWA at our tertiary referral medical center was performed. Eight patients were treated between 2014 and 2019. Diagnosis of CCA was made based on histopathological studies of samples obtained by surgical resection or percutaneous liver biopsy. All procedures were performed under computed tomography (CT) guidance using a high-power single antenna MWA system. General anesthesia was used for all procedures. Patient medical history, procedural technical information, outcomes, and follow-up data were reviewed. Progression-free survival was estimated with a Kaplan-Meier curve. Results: A total of 25 tumors with an average size of 2.2 ± 1.7 cm (range 0.5-7.8) were treated with MWA. Our cohort consisted of eight patients (4 males and 4 females) with an average age of 69.3 ± 5.7 years (range 61-79). Three out of eight (3/8, 37.5%) patients were treated initially with surgical resection. NASH-related cirrhosis was documented in 3/8 (37.5%) patients, while 1/8 (12.5%) had alcoholic cirrhosis; the remaining 4 patients (4/8, 50%) did not have cirrhosis. All patients were discharged within 24 h after ablation. Average total follow-up time was 10.6 ± 11.8 months (range 0-41). The incomplete ablation rate and local recurrence rate were 4% (1/25 lesions) and 12% (3/25 lesions), respectively. Conclusion: In patients who do not qualify for surgical resection, MWA is a safe alternative therapy for the treatment of intrahepatic CCA.

Lymphoepithelioma-Like Cholangiocarcinoma with Hepatitis C Virus Infection Treated by Microwave Ablation: A Literature Review and Case Report

Sonography-Guided Percutaneous Microwave Ablation of Intrahepatic Primary Cholangiocarcinoma

Microwave Ablation in Treating Intrahepatic Recurrence of Hepatocellular Carcinoma after Liver Transplantation: an Analysis of 11 Cases

Ultrasound-Guided Percutaneous Microwave Ablation for Hepatocellular Carcinoma in the Caudate Lobe

Percutaneous Microwave Ablation for Hepatocellular Carcinoma Adjacent to Large Vessels: A Long-Term Follow-Up

[Complications and Clinical Outcomes of Microwave Ablation for Liver Metastatic Cholangiocarcinoma after Bilioenteric Anastomosis].

Microwave Ablation Assisted by a Real-Time Virtual Navigation System for Hepatocellular Carcinoma Undetectable by Conventional Ultrasonography

Efficacy analysis for percutaneous microwave ablation of intrahepatic cholangiocarcinoma

Percutaneous Microwave Ablation for Liver Tumours Adjacent to the Marginal Angle.

Liver Abscess As a Complication of Microwave Ablation for Liver Metastatic Cholangiocarcinoma after Bilioenteric Anastomosis.

Clinical Study of the Ultrasound-guided Microwave Ablation Combined with Iodine-125 Implantation in the Treatment of Liver Cancer

Clinical Evaluation of Ultrasound-Guided Percutaneous Microwave Ablation of Hepatocellular Carcinoma Adjacent to the Gastrointestinal Tract

Clinical and Survival Outcomes of Percutaneous Microwave Ablation for Intrahepatic Cholangiocarcinoma

Learning Curve of Microwave Ablation for Liver Cancers

Sequential Thermal Ablation in Combination with Sclerotherapy Using Lauromacrogol As a Successful Translative Therapy for an Unresectable Huge Biliary Cystadenocarcinoma: the First Experience Assisted by Contrast-Enhanced Ultrasound.

Treatment Of Liver Tumours Adjacent To Hepatic Hilum With Percutaneous Microwave Ablation Combined With Ethanol Injection: A Pilot Study

Microwave Ablation Vs. Surgical Resection for Treatment Naïve Hepatocellular Carcinoma Within the Milan Criteria: a Follow-Up of at Least 5 Years

Lymphoepithelioma-like Intrahepatic Cholangiocarcinoma with Epstein-Barr Virus Infection: Report of a Rare Case

Percutaneous microwave ablation for early-stage intrahepatic cholangiocarcinoma: A single-institutional cohort

Laparoscopic microwave ablation therapy for the treatment of liver cancer closed to gallbladder

Ultrasound-guided Percutaneous Microwave Ablation for Hepatocellular Carcinoma Originating in the Caudate Lobe: A Pilot Clinical Study